USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

PortfoliosPositionsRebalanceAnalyzeOptimize Suggest Industries

US Market Closed: Feb 9, 19:22 PM 2012

NYSE 8081.25 1.73 Index Moved Down

NASDAQ 2927.23 11.37 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ARDM and BPTH...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Aradigm Corp and

Bio-Path Holdings

Volatility

Matrix

Run Correlation

Diversification

Average diversification

Overlapping area represents amount of risk that can be diversified away by holding Aradigm Corp and Bio-Path Holdings in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.15

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Suggest

0.13

Intraday

One Month

^(0.00)

3.70%

ARDM

OTCBB

Aradigm Corp

P/B Ratio	11.25	Open	0.13
Day Low	0.13	Market Cap	25.7M
Volume	78038	Last Close	0.135
Last Traded	2/9/2012	Year High	Not Applicable
Percent Change	3.70%	EBITDA	-9.9M
Absolute Change	0.00	Time	Not Applicable
Book Value	0.012	EPS	-0.051
Day High	0.131	Target Price	0.83
Current EPS	-0.051	This Year EPS	-0.06
Next Year EPS	-0.06	Current PE	Not Applicable

Tristel PLC - Directorate Change

2011-10-24

Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2012 on February 13

2012-02-08

Aradigm to Present at Biotech Showcase 2012 on January 9

2012-01-05

Aradigm Selects Pulmaquin? for Phase 3 Development and Announces Issuance of Its First U.S. Patent Covering Inhaled Ciprofloxacin Formulations

2011-12-07

ARADIGM CORP Financials

2011-11-17

0.3

Intraday

One Month

^(0.06)

16.67%

BPTH

OTCBB

Bio-Path Holdings

P/B Ratio	6.32	Open	0.3199
Day Low	0.30	Market Cap	17.4M
Volume	11000	Last Close	0.36
Last Traded	2/9/2012	Year High	Not Applicable
Percent Change	16.67%	EBITDA	-2.3M
Absolute Change	0.06	Time	Not Applicable
Book Value	0.057	EPS	-0.043
Day High	0.3199	Target Price	3.00
Current EPS	-0.043	This Year EPS	Not Applicable

BIO-PATH HOLDINGS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits

2012-02-08

Bio-Path Holdings Successfully Completes Second Cohort in Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia

2012-02-07

Biotechs to Watch at the 2012 San Francisco Healthcare Confrences

2012-01-09

Bio-Path Holdings to Present at the Biotech Showcase? 2012 Conference

2012-01-04

Biotechs to Watch at the 2012 San Francisco Healthcare Confrences

2012-01-09